Pediatric asthma is mainly characterized by a T helper type (Th)-2-inflammation in which the release of interleukin (IL)-4, IL-13, IL-5, and the immunoglobulin E (IgE) production increase eosinophilic survival. Here, IL13 is linked to asthma.